REGEN BIOPHARMA, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
REGEN BIOPHARMA, INC. (RGBP) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$59.19 thousand for the 9-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2024-08-13
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-12-31 was $3.46K.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-12-31 was -$10.46K.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2021-12-31 was -$373.67K.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2020-12-31 was $0.00.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $69.83K.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$675.96K, a 192.96% decline from fiscal 2021.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2021 was $727.16K.
- REGEN BIOPHARMA, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2020 was -$7.86K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | -$59.19K 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | -$42.92K 10-Q · filed 2024-04-24 | ||||
| 2023-12-31 | $3.46K 10-Q · filed 2024-01-19 | ||||
| 2023-09-30 | $69.83K 10-K · filed 2023-11-20 | ||||
| 2023-06-30 | -$50.51K 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | $36.95K 10-Q · filed 2024-04-24 | $36.50K 10-Q · filed 2023-04-18 | |||
| 2022-12-31 | -$10.46K 10-Q · filed 2024-01-19 | ||||
| 2022-09-30 | -$675.96K 10-K · filed 2023-11-20 | ||||
| 2022-06-30 | -$616.17K 10-Q · filed 2023-07-25 | ||||
| 2022-03-31 | -$492.49K 10-Q · filed 2023-04-18 | ||||
| 2021-12-31 | -$373.67K 10-Q · filed 2023-01-19 | ||||
| 2021-09-30 | $727.16K 10-K · filed 2021-12-22 | ||||
| 2021-06-30 | $188.18K 10-Q · filed 2022-07-22 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2021-08-18 | ||||
| 2020-12-31 | $0.00 10-Q · filed 2022-01-20 | ||||
| 2020-09-30 | -$7.86K 10-K · filed 2021-12-22 | ||||
| 2020-06-30 | -$7.86K 10-Q/A · filed 2021-12-22 | ||||
| 2020-03-31 | -$7.86K 10-Q · filed 2021-08-18 | ||||
| 2019-12-31 | -$7.50K 10-Q · filed 2021-08-13 | ||||
| 2019-09-30 | -$164.00 10-K · filed 2021-08-04 | ||||
| 2019-06-30 | -$6.21K 10-Q · filed 2021-08-05 | ||||
| 2019-03-31 | $7.07K 10-Q · filed 2021-08-05 | ||||
| 2018-12-31 | $31.08K 10-Q · filed 2021-08-05 | ||||
| 2018-09-30 | -$261.95K 10-K · filed 2021-06-21 |